Lastly, CAR T cells expressing KLRG1 mirrored the results from the in vitro cytotoxicity assay and showed markedly increased tumor burden compared to all other CAR T cells, including the CD3ζ-only CAR, while showing modest efficacy compared to untransduced T cells (Fig. 7B). The gene discussed is KLRG1; the disease is neoplasm.